2013 Applying Next Generation Sequencing Brochure.pdf

Cover 

Conference-at-a-Glance 

Short Courses/Plenary Keynote 

Sequencing Strategies for Success 

Final Agenda 

August 19-21, 2013 | Omni Providence Hotel | Providence, RI 

Cambridge Healthtech Institute’s 

NG X Applying Next-Generation 

Sequencing 

Dynamics of the Microbiome 

on Health and Disease 

Single-Cell Sequencing 

Sequencing Data Analysis 

and Interpretation 

Sponsor & Exhibit Opportunities 

Hotel & Travel Information 

Registration Information 

Click Here to 

Register Online! 

Healthtech.com/Sequencing 

Register by 

July 12 

and Save up 

to $250 

August 19-20 

August 20-21 

Eighth Annual 

Sequencing Strategies 

for Success 

Inaugural 



Sixth Annual 



Inaugural 


Cambridge Healthtech Institute 

250 First Avenue, Suite 300 

Needham, MA 02494 

www.healthtech.com 

Corporate Sponsors: Corporate Support Sponsor: Healthtech.com/Sequencing

Cover 







Monday, August 19 morning 

Pre-Conference Short Courses* 


Monday, August 19 afternoon 


Dynamics of the Microbiome on Health 

and Disease 



Monday, August 19 evening 

Evening Networking Reception 



Tuesday, August 20 morning 


Dynamics of the Microbiome on Health 

and Disease 


Click Here to 



Register by 

July 12 

and Save up 

to $250 

Tuesday, August 20 afternoon 

Tuesday, August 20 evening 

Wednesday, August 21 morning 

Wednesday, August 21 afternoon 



Plenary Keynote Session 

Dinner Short Courses* 

Sequencing Data Analysis and 

Interpretation 

Sequencing Data Analysis and 

Interpretation 

*Separate Registration Required 





2

Cover 







Short Courses* 

Monday, August 19, 9:00 AM-12:00 pm 

SC1: Mapping Genomes in 3D 

Genomes are organized into 3-dimensional (3D) conformation in vivo through interactions 

with protein factors. In addition, DNA elements separated by long genomic distances are 

known to functionally interact. However, the details of these 3D structures and their role in 

gene transcription are largely unknown. This course is designed to provide an overview of 

sequencing strategies and analysis for probing the 3D structure of genomes. 

Jennifer E. Phillips-Cremins, Ph.D., Research Scientist, Job Dekker Laboratory, Program in 

Systems Biology, University of Massachusetts Medical School 

Yijun Ruan, Ph.D., Professor and Director for Genome Sciences, Jackson Laboratory for 

Genomic Medicine, The Jackson Laboratory 

Chia-Lin Wei, Ph.D., Group Lead, Sequencing Technologies, DOE Joint Genome Institute 

John-David Herlihy, Ph.D., Product Manager, Covaris, Inc. 

Alexander Seitz, M.D., CEO, Lexogen 

Michael Vishnevetsky, Ph.D., Vice President, WaferGen Biosystems, Inc. 

Tuesday, August 20, 6:00-9:00 pm 

SC3: Assembly and Alignment 

The most important first step in understanding next-generation sequencing data is the initial 

alignment or assembly. This course is designed to provide an overview of alignment and 

assembly algorithms, and comparisons for various applications. 

Gabe Rudy, Vice President, Product Development, Golden Helix and Author, “A Hitchhiker’s 

Guide to Next Generation Sequencing” 





SC2: Sample Prep 

The emergence of next-generation sequencing technologies has revolutionized genomic 

research. This dramatic advancement, however, still involves complicated and labor-intensive 

workflows for upstream sample preparation, library construction, and template amplification. 

Instructors share their solutions to prepare for sequencing runs (including the specific 

requirements of sequencing platforms) by addressing customizability, compatibility, and 

cost effectiveness. 

Stacey Broomall, Biologist, R&T, U.S. Army, Edgewood Chemical Biological Center 

*Separate Registration Required 



Click Here to 



Register by 

July 12 

and Save up 

to $250 

Jeffery A. Schloss, Ph.D., 

Director, Division of 

Genome Sciences, National 

Human Genome Research 

Institute, National Institutes 

of Health 

Dr. Schloss, in addition to his role at NIH, 

manages a grants program to develop 

technologies with which to sequence human 

genomes for $1,000 and coordinates the Centers 

of Excellence in Genomic Science program. 

He helped formulate and then led or served on 

interdisciplinary initiatives, including the NIH 

Bioengineering Consortium (BECON), the Trans- 

NIH Nano Task Force and the U.S. interagency 

National Nanotechnology Initiative. 

David Galas, Ph.D., 

Principal Scientist, 

Pacific Northwest 

Diabetes 

Research Institute 

Before joining Pacific Northwest 

Diabetes Research Institute, Dr. Galas was 

Professor and Senior Vice President at the 

Institute for Systems Biology, Chancellor and 

Norris Professor of Applied Life Science at 

the Keck Graduate Institute and Professor and 

Chairman of Molecular Biology at the University 

of Southern California. Involved in translating 

science into diagnostics and therapeutics in 

several biotechnology companies, he researches 

human genetics of complex diseases and the 

development and application of new technologies 

and computational methods. He has served on 

the NRC Board on Life Science, among other 

groups, and is a lifetime Associate of the 

National Academy of Sciences. 

Sherman Weissman, 

Ph.D., Sterling Professor 

of Genetics and Medicine, 

Yale University School 

of Medicine 

Dr. Weissman has long 

contributed to studies of the molecular biology 

of higher cells, focusing on the globin and MHC 

loci. Early accomplishments include identification 

of sequences for transcription termination 

and initiation for E. coli RNA polymerase and 

the sequencing of the SV40 virus. His lab has 

worked extensively on cDNA technology and 

has been developing methods for genome-scale 

analysis of individual and small numbers of cells. 

Widely experienced in genomic technology, Dr. 

Weissman has co-directed the Yale Center for 

Genomics and Proteomics, worked to develop 

technical approaches that can be applied to 

large-scale analysis, and participated in the 

NIHGR ENCODE project since its inception. 

Yaniv Erlich, Ph.D., 

Principal Investigator, 

Whitehead Fellow, 

Whitehead Institute for 

Biomedical Research 

Dr. Erlich earned his Ph.D. 

from the Watson School of Biological Sciences 

at Cold Spring Harbor Laboratory in 2010 and 

has received the Harold M. Weintraub Award, 

the IEEE/ACM-CS HPC Award, Goldberg-Lindsay 

Fellowship and Wolf Foundation Scholarship 

for Excellence in Exact Sciences. His research 

interests lie in computational human genetics 

and he was selected to be part of the 2010 

Tomorrow’s PIs team by Genome Technology. 





3

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





Eighth Annual 

August 19-20, 2013 

NG X Sequencing Strategies 

for Success Delivering Genomes at Exponential Rates 

As prices continue to drop and technology continues to improve, the purchase of a next-generation sequencing (NGS) platform is 

now a reality for most research laboratories. Once you have purchased a platform, however, how do you maximize the greatest 

potential for your investment? Realizing this potential requires efficient workflow strategies, careful experimental design, 

comprehensive targeted enrichment technologies, data analysis, management, and integration, in addition to maintaining your 

platform and people management all at maximum production. The central theme at CHI’s Sequencing Strategies for Success 

conference is efficient utilization of your NGS platform. Sessions will focus on common bottlenecks, case studies, real-world 

experiences and solutions from experienced NGS users. 

Monday, August 19 

8:30 am Short Course Registration and Morning Coffee 

9:00-12:00 pm Short Courses* (see page 3 for details) 



1:00 Main Conference Registration 

Sequencing Centers 

2:00 Chairperson’s Opening Remarks 

Lisa D. White, Ph.D., Associate Professor, Molecular and Human Genetics, Baylor College 

of Medicine 

2:10 Sequencing: Wonderful Adventure or Terrible Tragedy? 

Lisa D. White, Ph.D., Associate Professor, Molecular and Human Genetics, Baylor College 

of Medicine 

Applying next-generation sequencing (NGS) to clinical diagnostics promises to increase the 

rate of diagnoses, and as more correlations with phenotype are drawn, there is the promise of 

biomarker detection for prognosis and therapeutics. Taking NGS to the next step from a basic 

research procedure in a non-certified molecular lab to providing clinical sequencing requires a 

host of different procedures and a different laboratory culture than that found in basic research. 

The experience of launching NGS in a laboratory can run the gamut of wonderful adventure to 

terrible tragedy depending on preparedness, resources and support. This talk will cover some of 

the issues required to make the transition into an NGS CLIA-/CAP-certified laboratory. 

4 

2:40 Translational Science: From Basic Research to Genomic Medicine in an 

Academic Core Laboratory – Lessons Learned 

Nicholas P. Ambulos, Jr., Ph.D., Associate Professor, Microbiology and Immunology; Executive 

Director, School of Medicine Core Facilities; Director, Genomics Core Facility, University of 

Maryland School of Medicine 

Next-generation sequencing technology continues to improve and become more costeffective. 

Academic core laboratories have played a significant role in making this 

technology readily available to basic research laboratories. As a result, this technology 

is rapidly becoming the diagnostic tool of choice for many clinicians. The challenge we 

now face is how these academic core laboratories can provide comprehensive support to 

basic research, translational studies and clinical diagnostics and play a role in educating 

healthcare professionals. 

3:10 An Overview of the New York Genome Center 

Kevin V. Shianna, Ph.D., Senior Vice President, Sequencing Operations, New York 

Genome Center 

The NYGC initiated its sequencing operations in early 2012 and is building out to be one of 

the largest genome centers in North America. An overview of our experience to date will be 

presented along with future goals and challenges. 

3:40 Refreshment Break 

4:00 Combining Forces: Using All NGS Platforms to Advance Cancer 

Research at CGR 

Joseph Boland, Director, Research and Development, Cancer Genomics Research Laboratory, 

Stay Connected 

#NGx13 

>>

Cover 



1000 verified). These are added to the sample when 

it is first received and can be detected with a simple PCR and sequencing from any stage of 

the process. Sequence reads derived from this spike-in are generated along with the standard 

sequencing run and are used to confirm sample identity and determine cross-contamination 

levels. Successful spiking directly into blood and tissue samples prior to DNA extraction has 

been demonstrated. This methodology has been implemented in our targeted clinical diagnostic 

pipeline and has also been successfully validated for whole-genome sequencing. It is a very 

inexpensive, flexible and platform-agnostic solution to a pressing need. 

10:05 Coffee Break in the Exhibit Hall with Poster Viewing 

11:00 Using Multiplex ChIP-Seq to Explore Centromere Evolution in 

Budding Yeast 

Philippe Lefrancois, Ph.D., Faculty of Medicine, University of Montreal 

>>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

Cover 

Inaugural 











NG X Dynamics of the Microbiome 


Communities, Composition, and Computation 

Advances in next-generation sequencing and computation have elucidated the impact of human genomic variation; however, the 

impact of this variation is largely unexplored in the human microbiome. Now clinical and environmental researchers have the 

high-resolution tools to explore the emergent science of microbial communities and the ecosystems they inhabit. CHI’s Dynamics 

of the Microbiome on Health and Disease conference focuses on understanding the role of the microbiome to offer new insights 

into disease processes and discovery of new therapeutic strategies. 

Monday, August 19 

8:30 am Short Course Registration and Morning Coffee 

database. Our results show several new potential bacterial agents that may be associated with 

different diseases with unknown etiologies. We are currently in the process of translating these 

methods to the clinic where these approaches can immediately impact human health. 



Click Here to 



Register by 

July 12 

and Save up 

to $250 





9:00-12:00 pm Short Courses* (see page 3 for details) 



1:00 Main Conference Registration 

Communities and Composition 


Emma Allen-Vercoe, Ph.D., Assistant Professor, Molecular and Cellular Biology, University 

of Guelph 

»» 

Featured Presentation 

2:10 Metagenomic Platforms for Diagnostic, Microbial Composition and 

Etiologic Agent Discovery Applications 

Joseph Petrosino, Ph.D., Assistant Professor, Molecular Virology and Microbiology; Director, 

Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine 

Metagenomics strategies for etiologic agent discovery and diagnostic detection have multiple 

advantages over past methods: they are highly sensitive; they are able to detect sub-PFU levels of 

viruses in clinical samples; there is no requirement for propagation of the suspected agent in the 

laboratory; and there is no need for prior knowledge of the agent to be detected. For suspected 

bacterial agents we are using 16S rRNA gene and whole-genome shotgun surveys of diverse human 

samples to identify potential agents and antibiotic resistance profiles. For suspected viral agents 

we are sequencing randomly primed cDNA libraries and querying these data against a custom viral 

7 

2:40 Archaea and Fungi of the Human Gut Microbiome 

Christian Hoffmann, Research Scientist, Frederic D. Bushman Laboratory, Microbiology, 

Perelman School of Medicine, University of Pennsylvania 

We investigate associations of diet with fungal and archaeal populations in the gut 

microbiome, as well as interdomain relationships between bacteria, archaea and fungi in a 

cohort of 96 individuals. Diet relationships with microbial taxa were investigated regarding 

usual and recent dietary intake. 

3:10 Microbial Ecosystems Therapeutics: A New Paradigm in Medicine? 

Emma Allen-Vercoe, Ph.D., Assistant Professor, Molecular and Cellular Biology, University 

of Guelph 

It is now clearly recognized that the human gut microbial ecosystem is a critical factor in the 

maintenance of host health, and that disturbances in this ecosystem, leading to enduring 

imbalance (dysbiosis) are associated with an ever increasing number of disorders (for example, 

IBD, IBS, diabetes, asthma, autism). With this in mind, is it possible to harness the microbial 

Alumni Discount SAVE 20% 

Cambridge Healthtech Institute (CHI) appreciates your past participation at our events. Through 

loyalty like yours, CHI has been able to build this event into a must-attend for senior-level 

decision makers. As a result of the great loyalty you have shown us, we are pleased to extend 

to you the exclusive opportunity to save an additional 20% off the registration rate. Just check 

off the box marked Alumni Discount on the registration form to receive the discount! 

>>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





Inaugural 

NG X Single-Cell Sequencing 

Meeting the Challenge One Cell at a Time 


Over the past decade, NGS technologies have moved at a rapid pace, dramatically reducing costs, and making genome sequencing 

more routine. What was once unthinkable is now possible. However, most genomes are still sequenced from DNA extracted from 

multiple cells, which misses differences between cells that could be crucial in controlling gene expression, cell behavior, and drug 

response. Still, challenges for single-cell sequencing remain, including cell isolation, DNA amplification, and bioinformatics. As the 

techniques are being refined, subtle differences between cells, such as the tiny genomic rearrangements, will emerge. CHI’s Single- 

Cell Sequencing conference focuses on the links between cell variation in tissues and organ function and further elucidates the origins 

of diseases. 

Tuesday, August 20 

12:00 pm Main Conference Registration 

Sponsored by 

12:30 From Reads to Variants: Ten-Fold Reduction in Time 

and Cost with Improved Accuracy 

Rupert Yip, Ph.D., Director, Product Marketing, Bina Technologies 

Alignment and variant calling of raw NGS reads has been plagued by expensive HPC 

hardware and the bioinformatics personnel to support and maintain home-grown, opensource 

secondary analysis solutions. Such solutions can take up to weeks and $1000s per 

analysis. We present a genomic analysis platform that reduces, by ten-fold, the time and 

cost for secondary analysis while improving accuracy compared to standard pipelines. Our 

innovative model reduces costs by ten-fold while preventing hardware obsolescence. 


»» 



Toby Bloom, Ph.D., Deputy Scientific Director, Informatics, New York Genome Center 

2:10 A Revolution in DNA Sequencing Technologies: Challenges 

and Opportunities 

Jeffery A. Schloss, Ph.D., Director, Division of Genome Sciences, National Human Genome 

Research Institute, National Institutes of Health 

The initial sequencing of the human genome spurred an appetite for much more human 

10 

sequence information to better understand the contributions of human sequence variation to 

health and disease. However, despite dramatic reductions during the Human Genome Project, 

the cost of sequencing was clearly too high to collect the very large numbers of human 

and numerous other organism genome sequences needed to achieve that understanding. 

In 2004, NHGRI launched parallel programs to reduce the cost of sequencing a mammalian 

genome initially by two (in five years), and eventually by four orders of magnitude (in ten 

years). This presentation will summarize the technologies that are in high-throughput use 

to produce stunning amounts of sequence and related data and novel biological insights, 

and will emphasize technologies currently emerging and on the horizon that may provide 

human genome sequence data with the nature, quality, cost and turnaround time needed for 

applications in research and medicine. 

2:50 RNA is Everywhere: Characterizing the Spectra and Flux of RNA in 

Mammalian Circulation 

David Galas, Ph.D., Principal Scientist, Pacific Northwest Diabetes Research Institute 

The discovery of foreign RNA in blood and tissues of humans and mice raises many 

questions, including its origins, the mechanisms of its transport and stability and what, if any, 

functions it has. I will discuss what we know about circulating exRNA in human plasma and 

the use of NGS in the exploration of this new area of investigation in biology and medicine. 

3:30 Refreshment Break in the Exhibit Hall with Poster Viewing 

4:15 Genomics and the Single Cell 

Sherman Weissman, Ph.D., Sterling Professor of Genetics and Medicine, Yale University 

School of Medicine 

Studies of single cells are being approached by widely different methods, principally either 

florescence microscopy including super-high resolution methods, cloning and expansion 

>>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

90% coverage and enabling the 

detection of copy number variations and newly acquired single nucleotide variations with 

no false positives. Adapting MALBAC to transcriptome sequencing provides both improved 

technical reproducibility and increased sensitivity over existing methods and simultaneously 

sequencing the genome and transcriptome from the same cell allows us to probe the relation 

between genotype and phenotype in heterogeneous populations. 

3:05 Refreshment Break in the Exhibit Hall, Last Chance for Poster Viewing 

3:35 You Need More Power: Designing Cost-Effective Experiments for 

Measuring Differential Gene Expression Using RNA-Seq 

Michele Busby, Ph.D., Computational Biologist, Broad Institute; former Research Scientist, 

Biology, Gabor T. Marth Laboratory, Boston College 

RNA-Seq is a powerful tool for detecting differential gene expression, but only realizes 

its full potential when experiments are optimally designed. We will demonstrate how our 

computational tool Scotty can be used to design an experiment that contains an adequate 

number of samples sequenced to a sufficient depth to achieve experimental goals. We will 

further discuss how the performance of different RNA-Seq protocols can dramatically affect 

the power of an experiment and demonstrate computational techniques for assessing the 

performance of a protocol. 

4:05 Deconvolution of Heterogeneous Tissue Samples Based on 

RNA-Seq Data 

Ting Gong, Ph.D., Assistant Professor, Molecular Carcinogenesis, University of Texas MD 

Anderson Cancer Center 

The promising biomedical applications of NGS have spurred the development of new 

statistical methods to capitalize on the wealth of information contained in RNA-Seq datasets. 

However, for heterogeneous tissues, measurements of gene expression through RNA-Seq 

data can be confounded by the presence of multiple cell types present in each sample. 

Here, we present a statistical pipeline for deconvolution of heterogeneous tissues based on 

RNA-Seq data. 

4:35 Panel Discussion with Afternoon Speakers 

Moderator: Jan Vijg, Ph.D., Professor and Chair, Genetics, Albert Einstein College of Medicine 

Panelists: 

Christine Vogel, Ph.D., Assistant Professor, Center for Genomics and Systems Biology, New 

York University 

Alec Chapman, Research Scientist, X. Sunney Xie Laboratory, Chemistry and Chemical 

Biology, Harvard University 

Michele Busby, Ph.D., Computational Biologist, Broad Institute; former Research Scientist, 

Biology, Gabor T. Marth Laboratory, Boston College 

Ting Gong, Ph.D., Assistant Professor, Molecular Carcinogenesis, University of Texas MD 

Anderson Cancer Center 

Andrey Shabalin, Ph.D., Research Scientist, Edwin J.C.G. van den Oord Laboratory, Center for 

Biomarker Research and Personalized Medicine, Pharmacotherapy and Outcomes Science, 

Virginia Commonwealth University 

Christina Schweikert, Ph.D., Division of Computer Science, Mathematics and Science, St. 

John’s University 

5:00 Close of Single-Cell Sequencing Conference 





12

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





Sixth Annual 


NG X Sequencing Data Analysis 

and Interpretation Progress in the Pipeline 

Sequencing a genome is only the beginning. Several layers of analysis are necessary to convert raw sequence data into an understanding 

of functional biology. First, error sources in the original raw data from multiple platforms and diverse applications must be accounted for. 

Then, as computational methods for assembly, alignment, and variation detection continue to advance, a broad range of genetic analysis 

applications including comparative genomics, high-throughput polymorphism detection, analysis of coding and non-coding RNAs, and 

identifying mutant genes in disease pathways can be addressed. CHI’s Sequencing Data Analysis and Interpretation conference combines 

unique perspectives from a variety of researchers, engineers, biostatisticians, and software developers involved in NGS data analysis. 


12:00 pm Main Conference Registration 

Sponsored by 

12:30 From Reads to Variants: Ten-Fold Reduction in Time 

and Cost with Improved Accuracy 

Rupert Yip, Ph.D., Director, Product Marketing, Bina Technologies 

Alignment and variant calling of raw NGS reads has been plagued by expensive HPC 

hardware and the bioinformatics personnel to support and maintain home-grown, opensource 

secondary analysis solutions. Such solutions can take up to weeks and $1000s per 

analysis. We present a genomic analysis platform that reduces, by ten-fold, the time and 

cost for secondary analysis while improving accuracy compared to standard pipelines. Our 

innovative model reduces costs by ten-fold while preventing hardware obsolescence. 


»» 



Toby Bloom, Ph.D., Deputy Scientific Director, Informatics, New York Genome Center 

2:10 A Revolution in DNA Sequencing Technologies: Challenges 

and Opportunities 

Jeffery A. Schloss, Ph.D., Director, Division of Genome Sciences, National Human Genome 

Research Institute, National Institutes of Health 

The initial sequencing of the human genome spurred an appetite for much more human 

sequence information to better understand the contributions of human sequence variation to 

health and disease. However, despite dramatic reductions during the Human Genome Project, 

13 

the cost of sequencing was clearly too high to collect the very large numbers of human 

and numerous other organism genome sequences needed to achieve that understanding. 

In 2004, NHGRI launched parallel programs to reduce the cost of sequencing a mammalian 

genome initially by two (in five years), and eventually by four orders of magnitude (in ten 

years). This presentation will summarize the technologies that are in high-throughput use 

to produce stunning amounts of sequence and related data and novel biological insights, 

and will emphasize technologies currently emerging and on the horizon that may provide 

human genome sequence data with the nature, quality, cost and turnaround time needed for 

applications in research and medicine. 

PRESENT YOUR RESEARCH 

Gain further exposure by presenting your work in the poster 

sessions. To secure a poster board and inclusion in the conference 

materials, your abstract must be submitted, approved and your 

registration paid in full by July 12, 2013. 

Reasons you should present your research poster at this conference: 

• Your poster will be exposed to our international delegation. 

• Receive $50 off your registration. 

• Your poster abstract will be published in our conference materials. 

• Your research will be seen by leaders from top pharmaceutical, biotech, 

academic and government institutes. 

>>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 





>

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

Sponsorship, Exhibit, & 

Lead Generation Opportunities 

CHI offers comprehensive sponsorship packages which include presentation opportunities, exhibit 

space and branding, as well as the use of the pre and post-show delegate lists. Customizable 

sponsorship packages allow you to achieve your objectives before, during, and long after the 

event. Signing on early will allow you to maximize exposure to hard-to-reach decision makers 

Agenda Presentations 

Showcase your solutions to a guaranteed, highly-targeted audience. Package includes a 15 or 

30-minute podium presentation within the scientific agenda, exhibit space, on-site branding and 

access to cooperative marketing efforts by CHI. 

Breakfast & Luncheon Presentations 

Opportunity includes a 30-minute podium presentation. Boxed lunches are delivered into the 

main session room, which guarantees audience attendance and participation. A limited number 

of presentations are available for sponsorship and they will sell out quickly. Sign on early to 

secure your talk! 

Invitation-Only VIP Dinner/Hospitality Suite 

Sponsors will select their top prospects from the conference pre-registration list for an evening 

of networking at the hotel or at a choice local venue. CHI will extend invitations and deliver 

prospects. Evening will be customized according to sponsor’s objectives i.e.: 

• Purely social 

• Focus group 

• Reception style 

• Plated dinner with specific conversation focus 

Exhibit 

Exhibitors will enjoy facilitated networking opportunities with high-level conference delegates. 

Speak face-to-face with prospective clients and showcase your latest product, service, or solution. 

*Inquire about additional branding opportunities! 

Sponsoring Organization 

Official Sponsoring Publication 

Lead Sponsoring Publications 

Sponsoring Publications 

FierceBiotech 

THE BIOTECH INDUSTRY’S DAILY MONITOR 

Looking for additional ways to drive leads to your 

sales team? 

CHI can help! 

We offer clients numerous options for custom lead generation programs to address 

their marketing and sales needs, including: 

Custom Lead Generation Programs: 

• Targeted campaign promotion to unparalleled database of 800,000+ individuals 

in the life sciences 

• Experienced marketing team promotes campaign, increasing awareness and leads 

Live Webinars: 

• Assistance in procuring speakers 

• Experienced moderators 

• Dedicated operations team to coordinate all efforts 

Whitepapers: 

• Industry recognized authors, with vast editorial experience, available to help write 

your white paper 

CHI also offers market surveys, podcasts, and more! 

To customize your participation at this 

event, please contact: 

Jay Mulhern 

Business Development Manager 

781-972-1359 

jmulhern@healthtech.com 

Web Partners 





16

Cover 












Click Here to 



Register by 

July 12 

and Save up 

to $250 

Hotel & Travel 

Information 

Conference Hotel: 

Omni Providence Hotel 

One West Exchange Street 

Providence, RI 02903 

Phone: 401-598-8000 

Discounted Room Rate: $165 s/d 

Discounted Reseveration Cut-off Date: July 19, 2013 

Please visit our conference website to make your reservation online or you may call the hotel 

directly. You will need to identify yourself as a Cambridge Healthtech Institute conference attendee 

to receive the discounted room rate with the host hotel. Reservations made after the cut-off date or 

after the group room block has been filled (whichever comes first) will be accepted on a space and 

rate-availability basis. Rooms are limited, so please book early. 

Why Stay at the Omni Providence? 

The Omni Providence was awarded the prestigious “Highest in Hotel Guest Satisfaction among 

Upper-Upscale Hotel Chains” award by JD Power and Associates for 2012. In addition to being 

attached to the upscale Providence Place Mall, it is within walking distance to some of the city’s best 

historic attractions, gourmet restaurants, shopping and entertainment. The hotel features an indoor 

pool and complimentary wireless internet in all guest rooms. 

We realize you have many choices when making your travel arrangements. Please understand that 

reserving your room in the CHI room block at the conference hotel allows you to take full advantage 

of the conference sessions, events and networking opportunities, and ensures that our staff will be 

available to help should you have any issues with your accommodations. 

Flight Discounts: 

Special discounts have been established with American Airlines for this conference. 

• Call American Airlines 1-800-433-1790 and use Conference code 8283BJ. 

• Go online www.aa.com/group and enter Conference code 8283BJ in promotion discount box. 

• Contact our dedicated travel agent Rona Meizler at 1-617-559-3735 or 

rona.meizler@protravelinc.com. 

Car Rental Discounts: 

Special discounts have been established with Hertz for this conference. 

Please use one of the following methods: 

• Call Hertz 1-800-654-3131 and use our Hertz Convention Number (CV): 04KL0004. 

• Go online www.hertz.com and use our Hertz Convention Number (CV): 04KL0004. 





17

Cover 




How to Register: Healthtech.com/Sequencing 

reg@healthtech.com • P: 781.972.5400 or Toll-free in the U.S. 888.999.6288 

Please use keycode DTD P when registering 

short courses 

Commercial 

Academic, Government, Hospital-affiliated 

One short course $695 $395 

Two short courses $995 $695 

Receive a FREE eNewsletter by signing up 

at chimediagroup.com 

The latest industry news, commentary 

and highlights from Bio-IT World 

Innovative management in clinical trials 









Click Here to 



Register by 

July 12 

and Save up 

to $250 





Monday, August 19 Tuesday, August 20 


SC3: Assembly and Alignment 


SC4: Cancer Genetics and Epigenetics 

Conference Pricing 

BASIC PACKAGE (Includes access to 1 conference, excludes short courses) 

Advance Registration Discount until July 12, 2013 $1495 $695 

Registrations after July 12, 2013, and on-site $1745 $775 

STANDARD PACKAGE (Includes access to 2 conferences, excludes short courses) 

Advance Registration Discount until July 12, 2013 $2145 $1045 

Registrations after July 12, 2013, and on-site $2345 $1095 

August 19-20, 2013 August 20-21, 2013 



Dynamics of the Microbiome on Health and Disease 

Sequencing Data Analysis and Interpretation 

Conference Discounts 

Poster Submission – Discount ($50 Off) 

Poster abstracts are due by July 12, 2013. Once your registration has been fully processed, we will send an email containing a 

unique link allowing you to submit your poster abstract. If you do not receive your link within 5 business days, please contact 

jring@healthtech.com. *CHI reserves the right to publish your poster title and abstract in various marketing materials and products. 

Alumni Discount SAVE 20%: We appreciate your past participation at our events. Through loyalty like yours, this event has become a must-attend 

for senior level decision makers. As a result of your great loyalty, we are pleased to extend this exclusive opportunity to save an additional 20% off 

the registration rate. Simply select the “Alumni Discount” option on the online registration form to take advantage of this special offer. 

NGS Leaders Discounts: Members of the NGS Leaders community will receive a $50 discount off the conference registration. 

REGISTER 3 - 4th IS FREE: Individuals must register for the same conference or conference combination and submit completed registration form 

together for discount to apply. Please reproduce this registration form as needed. 

Group Discounts are Available! Special rates are available for multiple attendees from the same organization. For more information on group 

discounts contact David Cunningham at 781-972-5472. 

*Alumni, NGS Leaders, Twitter, LinkedIn, Facebook or any other promotional discounts cannot be combined. Discounts not applicable on Event Short Courses. 

If you are unable to attend but would like to purchase the NG X Applying Next-GenerationSequencing CD for $750 (plus shipping), 

please visit Healthtech.com/sequencing. Massachusetts delivery will include sales tax. 

A series of diverse reports designed to 

keep life science professionals informed 

of the salient trends in pharmaceutical 

technology, business, clinical development, 

and therapeutic disease markets. 

For a detailed list of reports, visit 

InsightPharmaReports.com, or contact Rose 

LaRaia, rlaraia@healthtech.com, +1-781- 

972-5444. 

Barnett is a recognized leader in clinical 

education, training, and reference guides 

for life science professionals involved in 

the drug development process. For more 

information, visit barnettinternational.com. 

Cambridge Healthtech Associates 

(CHA) leverages its extensive network 

and unique collaborative model in 

consulting, technology evaluations 

and community-based communication 

services to help clients in the life 

sciences industry commercialize and 

penetrate the marketplace to increase 

revenue. Visit www.chacorporate.com. 

Additional registration details 

Each registration includes all conference 

sessions, posters and exhibits, food 

functions, and access to the conference 

proceedings link. 

Handicapped Equal Access: In accordance 

with the ADA, Cambridge Healthtech 

Institute is pleased to arrange special 

accommodations for attendees with 

special needs. All requests for such 

assistance must be submitted in writing 

to CHI at least 30 days prior to the start 

of the meeting. 

To view our Substitutions/ 

Cancellations Policy, go to 

http://www.healthtech.com/regdetails 

Video and or audio recording of any kind 

is prohibited onsite at all CHI events.

2013 Applying Next Generation Sequencing Brochure.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?